NEWS
News
Julphar to offset AED 561.7m accumulated losses
Gulf Pharmaceutical Industries (Julphar) announced it would authorize the use of AED 184.8...
October 1st, 2019
Kahira Pharmaceuticals approves dividends, bonus shares for FY18/19
Kahira Pharmaceuticals announced that its shareholders approved distributing cash dividend...
September 30th, 2019
News
Alexandria Pharmaceuticals approves EGP 11.2/shr dividend for FY18/19
Alexandria Pharmaceuticals and Chemical Industries announced that its shareholders approve...
September 30th, 2019
OPIC pens deal to invest $10m in Egypt’s LimeVest Partners
The US financial institution Overseas Private Investment Corporation (OPIC) signed a commi...
September 26th, 2019
News
October Pharma's board approves EGP 60m capital hike
The board of directors of October Pharma assented to increase the firm’s capital by EGP 60...
September 24th, 2019
Julphar’s CEO resigns; last working day in 2M
Gulf Pharmaceutical Industries (Julphar) announced that its Jerome Carle who performs as i...
September 17th, 2019
News
Memphis Pharmaceutical’s losses shrink 46% in FY18/19
Memphis Pharmaceutical and Chemical Industries reported a 45.7% year-on-year decrease in i...
September 10th, 2019
UAE’s EMAC, ADGMAC ink maritime arbitration development MoU
Emirates Maritime Arbitration Centre (EMAC) and the Abu Dhabi Global Market Arbitration Ce...
September 9th, 2019
ANALYSIS
Analysis
85pc of critical illness claims in the UAE are cancer, heart disease - data
Recent figures from insurance giant Zurich International Life showed that cancer (44 per c...
March 15th, 2017
Analysis
Health care crumbles as Yemen war rages
Yemen, which has been facing unrest for the past five years, is struggling to cope with a...
February 23rd, 2016
Analysis
Health situation in Kuwait
A Supreme Planning Council report on human development titled “Social Cohesion: National P...
August 30th, 2015
REPORTS
Tunisia Healthcare & Pharmaceuticals July 2015
Tunisia’s pharmaceutical industry is strong, and has continued to grow since the privatisation of the sector in the 1980s. Currently, there are several local pharmaceutical production companies, producing both generics…